Article | Published:

Body composition, energy expenditure and physical activity

Serum advanced glycation end products are not associated with muscle strength in hemodialysis patients

European Journal of Clinical Nutritionvolume 73pages617623 (2019) | Download Citation



Advanced glycation end products (AGEs) are elevated in patients with renal failure and may potentially affect skeletal muscle. The aim of this study was to evaluate whether serum concentrations of AGEs are associated with muscle strength in hemodialysis (HD) patients, since this association is not clear in the literature.


This research has a cross-sectional design and included 96 patients on hemodialysis treatment (20–69 years). Serum AGEs (ELISA), three-day dietary records, anthropometric and bioimpedance variables and handgrip strength (HGS) were analysed. Serum AGEs were analyzed by ELISA test.


Men’s HGS were significantly higher than women’s (p < 0.001). Serum AGEs of the individuals of the highest HGS quartile versus the lowest quartile were 11.27 ± 2.52 and 9.06 ± 2.14 (µg/mL), respectively (p = 0.02). After adjustment for potential confounders, the correlation between serum AGEs and HGS lost statistical significance. The main factors that were associated to muscle strength were aging, BMI, percentage of fat-free mass and serum albumin.


Contrary to our hypothesis, serum AGEs were not associated with muscular strength in HD patients. These results suggest that serum AGE is not a good indicator of muscle strength in this population and others factors related to the disease may be more important and significant in reducing muscle strength than the serum concentrations of AGEs alone.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Stevens PE, Adeera L. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825–30.

  2. 2.

    Sesso RC, Lopes AA, Thomé FS, Lugon JR, Watanabe Y, dos Santos DR. Report of the Brazilian chronic dialysis census 2012. J Bras Nefrol. 2014;36:48–53.

  3. 3.

    Godfrey AR. Impact of glucose levels on advanced glycation end products in hemodialysis. Hemodial Int. 2007;11:278–85.

  4. 4.

    Mallipattu SK, He JC, Uribarri J. Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients. Semin Dial. 2012;25:529–38.

  5. 5.

    Nongnuch A, Davenport A. The effect of vegetarian diet on skin autofluorescence measurements in haemodialysis patients. Br J Nutr. 2015;113:1040–3.

  6. 6.

    Poulsen MW, Hedegaard RV, Andersen JM, de Courten B, Bügel S, Nielsen J, et al. Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol. 2013;60:10–37.

  7. 7.

    Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4:90–102.

  8. 8.

    Barbosa JHP, Oliveira SL, Seara LTE. O papel dos produtos finais da glicação avançada (AGEs) no desencadeamento das complicações vasculares do diabetes. Arq Bras Endocrinol Metabol. 2008;52:940–50.

  9. 9.

    Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–46.

  10. 10.

    De la Maza MP, Uribarri J, Olivares D, Hirsch S, Leiva L, Barrera G, et al. Weight increase is associated with skeletal muscle immunostaining for advanced glycation end products, receptor for advanced glycation end products, and oxidation injury. Rejuvenation Res. 2008;11:1041–8.

  11. 11.

    Dalal M, Ferrucci L, Sun K, Beck J, Fried LP, Semba RD. Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women. J Gerontol A Biol Sci Med Sci. 2009;64:132–7.

  12. 12.

    Momma H, Niu K, Kobayashi Y, Guan L, Sato M, Guo H, et al. Skin advanced glycation end product accumulation and muscle strength among adult men. Eur J Appl Physiol. 2011;111:1545–52.

  13. 13.

    Mori H, Kuroda A, Araki M, Suzuki R, Taniguchi S, Tamaki M, et al. Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes. J Diabetes Investig. 2017;8:377–82.

  14. 14.

    Chiu C-Y, Yang R-S, Sheu M-L, Chan D-C, Yang T-H, Tsai K-S, et al. Advanced glycation end products induce skeletal muscle atrophy and dysfunction in diabetic mice via an RAGE-mediated AMPK-downregulated Akt Pathway. J Pathol. 2016;238:470–82.

  15. 15.

    Haus JM, Carrithers JA, Trappe SW, Trappe TA. Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol. 2007;103:2068–76.

  16. 16.

    Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European working group on sarcopenia in older people: sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39:412–23.

  17. 17.

    Leal VO, Stockler-Pinto MB, Farage NE, Aranha LN, Fouque D, Anjos LA, et al. Handgrip strength and its dialysis determinants in hemodialysis patients. Nutrition. 2011;27:1125–9.

  18. 18.

    Leal VO, Mafra D, Fouque D, Anjos LA. Use of handgrip strength in the assessment of the muscle function of chronic kidney disease patients on dialysis: A systematic review. Nephrol Dial Transplant. 2011;26:1354–60.

  19. 19.

    Browner WS, Newman TB, Hulley S.B. Estimating sample size and power: applications and examples. In: Hulley SB, Browner WS, Grady DG, Newman TB, editors. Designing clinical research, 3rd edn. Philadelphia: Lippincott Williams & Wilkins; 2007. pp. 65–94.

  20. 20.

    Reis MM, Arantes PMM. Medida da força de preensão manual-validade e confiabilidade do dinamômetro saehan. Fisioter e Pesqui. 2011;18:176–81.

  21. 21.

    Schlüssel MM, dos Anjos LA, de Vasconcellos MTL, Kac G. Reference values of handgrip dynamometry of healthy adults: A population-based study. Clin Nutr. 2008;27:601–7.

  22. 22.

    Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, et al. National Kidney Foundation: KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis. 2015;66:884–930.

  23. 23.

    Habitcht JP. Estandarización de métodos epidemiológicos cuantitativos sobre el terreno. Bol Oficina Sanit Panam. 1974;76:375–84.

  24. 24.

    Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Composition of the ESPEN Working Group. Clin Nutr. 2004;23:1226–43.

  25. 25.

    Conway J, Ingwersen L, Moshfegh A. Effectiveness of the USDA 5-step multiple-pass method to assess food intake in obese and non-obese women. Am J Clin Nutr. 2003;77:71–78.

  26. 26.

    Monego E, Peixoto MRG, Santiago R, Gil MF, Cordeiro MM, Campos MI, et al. Alimentos brasileiros e suas porções - Um guia para avaliação do consumo alimentar. Rubio: Rio de Janeiro; 2013. p. 107.

  27. 27.

    Willett WC, Howe GR, Kushi LW. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–1228S.

  28. 28.

    Pinto AP, Ramos CI, Meireles MS, Kamimura MA, Cuppari L. Impact of hemodialysis session on handgrip strength. J Bras Nefrol. 2015;37:451–7.

  29. 29.

    Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Baràny P, Heimbürger O, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014;9:1720–8.

  30. 30.

    Kittiskulnam P, Chertow GM, Carrero JJ, Delgado C, Kaysen GA, Johansen KL. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017;92:238–47.

  31. 31.

    Snow LM, Thompson LV. Influence of insulin and muscle fiber type in nepsilon- (carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin- induced diabetes mellitus. Pathobiology. 2009;76:227–34.

  32. 32.

    Thompson LV. Age-related muscle dysfunction. Exp Gerontol. 2009;44:106–11.

  33. 33.

    Semba RD, Arab L, Sun K, Nicklett EJ, Ferrucci L. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. J Nutr. 2011;141:1726–30.

  34. 34.

    Payne GW. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation. 2006;13:343–52.

  35. 35.

    Bansal S, Chawla D, Siddarth M, Banerjee BD, Madhu SV, Tripathi AK. A study on serum advanced glycation end products and its association with oxidative stress and paraoxonase activity in type 2 diabetic patients with vascular complications. Clin Biochem. 2013;46:109–14.

Download references


The authors would like to thank the Coordenação de Aperfeiçoamento de Nível Superior (CAPES) for the scholarship and Rodrigo Tallada Iborra (Laboratório de Lipides (LIM 10), Hospital das Clinicas (HCFMUSP) da Faculdade de Medicina da Universidade de Sao Paulo, BR) for measuring serum AGEs. MP received a grant from Fundação de Amparo à Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Author information


  1. Graduate Program in Nutrition and Health, Faculty of Nutrition, Federal University of Goias, Goiania, Brazil

    • Debora M. Silva
    • , Nayara P. Queiroz
    • , Ana Tereza V. S. Freitas
    •  & Maria do Rosário G. Peixoto
  2. Laboratório de Lipides (LIM 10), Hospital das Clinicas (HCFMUSP) da Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, SP, Brazil

    • Marisa Passarelli


  1. Search for Debora M. Silva in:

  2. Search for Nayara P. Queiroz in:

  3. Search for Ana Tereza V. S. Freitas in:

  4. Search for Marisa Passarelli in:

  5. Search for Flávia Campos Corgosinho¹ in:

  6. Search for Maria do Rosário G. Peixoto in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Maria do Rosário G. Peixoto.

About this article

Publication history





Issue Date